APA

Sagawa N., Ohno S., Hiratsuka T., Kondo N., Iwata H., Bando H., Ohyama T., Ishida M., Kono Y., Nakajima K., Empuku S., Nishikawa S., Irie Y., Inomata M. & Kitano S. (20191206). The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial. : Breast cancer research and treatment.

Chicago

Sagawa Noriko, Ohno Shinji, Hiratsuka Takahiro, Kondo Naoto, Iwata Hiroji, Bando Hiroko, Ohyama Tetsuji, Ishida Mayumi, Kono Yohei, Nakajima Kentaro, Empuku Shinichiro, Nishikawa Setsuko, Irie Yoshiko, Inomata Masafumi and Kitano Seigo. 20191206. The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial. : Breast cancer research and treatment.

Harvard

Sagawa N., Ohno S., Hiratsuka T., Kondo N., Iwata H., Bando H., Ohyama T., Ishida M., Kono Y., Nakajima K., Empuku S., Nishikawa S., Irie Y., Inomata M. and Kitano S. (20191206). The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial. : Breast cancer research and treatment.

MLA

Sagawa Noriko, Ohno Shinji, Hiratsuka Takahiro, Kondo Naoto, Iwata Hiroji, Bando Hiroko, Ohyama Tetsuji, Ishida Mayumi, Kono Yohei, Nakajima Kentaro, Empuku Shinichiro, Nishikawa Setsuko, Irie Yoshiko, Inomata Masafumi and Kitano Seigo. The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial. : Breast cancer research and treatment. 20191206.